David Gardiner

3.9k total citations · 1 hit paper
38 papers, 1.6k citations indexed

About

David Gardiner is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, David Gardiner has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in David Gardiner's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (6 papers). David Gardiner is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (6 papers). David Gardiner collaborates with scholars based in United States, United Kingdom and Germany. David Gardiner's co-authors include Fiona McPhee, Dennis M. Grasela, Timothy Eley, Megan Wind‐Rotolo, Eric Lawitz, C Pasquinelli, Anna S. Lok, Gregory T. Everson, Robert Reindollar and Dessislava I. Dimitrova and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

David Gardiner

36 papers receiving 1.5k citations

Hit Papers

Preliminary Study of Two Antiviral Agents for Hepatitis C... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
    2012 454 citations Anna S. Lok, David Gardiner et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gardiner United States 17 955 944 461 269 171 38 1.6k
Uri Lopatin United States 18 1.1k 1.2× 749 0.8× 819 1.8× 328 1.2× 85 0.5× 32 2.0k
Sharon Cookson United Kingdom 15 351 0.4× 262 0.3× 252 0.5× 322 1.2× 127 0.7× 20 1.1k
Gabriella Verucchi Italy 21 1.5k 1.5× 1.5k 1.6× 286 0.6× 101 0.4× 78 0.5× 86 2.0k
Richard L. Greenman United States 12 1.3k 1.3× 506 0.5× 408 0.9× 312 1.2× 106 0.6× 22 1.9k
Makoto Yoshiba Japan 24 1.1k 1.1× 1.2k 1.3× 239 0.5× 118 0.4× 160 0.9× 50 1.8k
Mithat Bozdayı Türkiye 28 1.7k 1.8× 1.7k 1.8× 211 0.5× 174 0.6× 104 0.6× 108 2.3k
Cyrille Bisseyé Gabon 21 618 0.6× 267 0.3× 289 0.6× 257 1.0× 73 0.4× 97 1.5k
Nobuhiko Sasaki Japan 11 532 0.6× 968 1.0× 502 1.1× 57 0.2× 80 0.5× 19 1.3k
Jamal Sarvari Iran 18 361 0.4× 178 0.2× 192 0.4× 164 0.6× 178 1.0× 93 921
Nancy P. Lam United States 10 1.4k 1.5× 1.6k 1.7× 332 0.7× 174 0.6× 41 0.2× 14 2.2k

Countries citing papers authored by David Gardiner

Since Specialization
Citations

This map shows the geographic impact of David Gardiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gardiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gardiner more than expected).

Fields of papers citing papers by David Gardiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gardiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gardiner. The network helps show where David Gardiner may publish in the future.

Co-authorship network of co-authors of David Gardiner

This figure shows the co-authorship network connecting the top 25 collaborators of David Gardiner. A scholar is included among the top collaborators of David Gardiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gardiner. David Gardiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Dung N., Jafar Sadik Shaik, Courtney Tiffany, et al.. (2021). Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague. British Journal of Clinical Pharmacology. 88(2). 416–428. 9 indexed citations
2.
Stinca, Sara, Thomas W. Barnes, Johannes Schulte-Pelkum, et al.. (2021). Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches. PLoS ONE. 16(11). e0259731–e0259731. 6 indexed citations
3.
Vegvari, Carolin, Yonatan H. Grad, Peter J White, et al.. (2020). Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea. Eurosurveillance. 25(43). 8 indexed citations
4.
Colston, Elizabeth, Dennis M. Grasela, David Gardiner, et al.. (2018). An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients. PLoS ONE. 13(6). e0198158–e0198158. 23 indexed citations
5.
6.
Eley, Timothy, Shu‐Pang Huang, Bing He, et al.. (2014). The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus. Clinical Drug Investigation. 34(9). 661–671. 17 indexed citations
7.
Lok, Anna S., David Gardiner, Christophe Hézode, et al.. (2013). Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders. Journal of Hepatology. 60(3). 490–499. 111 indexed citations
8.
McPhee, Fiona, Dennis Hernandez, Fei Yu, et al.. (2013). Resistance Analysis of Hepatitis C Virus Genotype 1 Prior Treatment Null Responders Receiving Daclatasvir And Asunaprevir. Hepatology. 58(3). 902–911. 98 indexed citations
9.
10.
Rahav, Galia, Edward T. Zito, David Gardiner, et al.. (2012). A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. BMC Infectious Diseases. 12(1). 297–297. 27 indexed citations
11.
Rosenbaum, Matthew D., David Gardiner, & Dorcas P. O’Rourke. (2012). Abdominal mass in a New Zealand white rabbit (Oryctolagus cuniculus). Lab Animal. 42(1). 19–22. 1 indexed citations
12.
Lok, Anna S., David Gardiner, Eric Lawitz, et al.. (2012). Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1. New England Journal of Medicine. 366(3). 216–224. 454 indexed citations breakdown →
13.
Franco, David, Weimin Liu, David Gardiner, Beatrice H. Hahn, & David D. Ho. (2011). CD40L-Containing Virus-Like Particle as a Candidate HIV-1 Vaccine Targeting Dendritic Cells. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(5). 393–400. 24 indexed citations
14.
Gardiner, David, Gary Dukart, Angel Cooper, & Timothy Babinchak. (2009). Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials. Clinical Infectious Diseases. 50(2). 229–238. 73 indexed citations
15.
Gardiner, David, et al.. (2009). A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A. Vaccine. 27(27). 3598–3604. 62 indexed citations
16.
Huang, Yaoxing, et al.. (2008). Design, Construction, and Characterization of a Dual-Promoter Multigenic DNA Vaccine Directed Against an HIV-1 Subtype C/B′ Recombinant. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(4). 403–411. 16 indexed citations
17.
Gardiner, David, et al.. (2006). Mortality and Gram-negative rod bacteraemia in the intensive care unit. Journal of Hospital Infection. 62(4). 453–457. 9 indexed citations
18.
Gardiner, David, Yaoxing Huang, Sankha S. Basu, et al.. (2005). Multiple-site DNA vaccination enhances immune responses in mice. Vaccine. 24(3). 287–292. 10 indexed citations
19.
Gardiner, David, et al.. (2002). Prevalence and Acquisition of Vancomycin-Resistant Enterococci in a Medical Intensive Care Unit. Infection Control and Hospital Epidemiology. 23(8). 466–468. 6 indexed citations
20.
Kraemer, William J., David Gardiner, Scott E. Gordon, et al.. (2001). Differential effects of exhaustive cycle ergometry on concentric and eccentric torque production. Journal of science and medicine in sport. 4(3). 301–309. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uri Lopatin Breakdown of academic impact, for papers by Sharon Cookson Breakdown of academic impact, for papers by Gabriella Verucchi Breakdown of academic impact, for papers by Richard L. Greenman Breakdown of academic impact, for papers by Makoto Yoshiba Breakdown of academic impact, for papers by Mithat Bozdayı Breakdown of academic impact, for papers by Cyrille Bisseyé Breakdown of academic impact, for papers by Nobuhiko Sasaki Breakdown of academic impact, for papers by Jamal Sarvari Breakdown of academic impact, for papers by Nancy P. Lam
Rankless by CCL
2026